SCHEMBL9980974

SCHEMBL9980974

CCOC(=O)C1(NC(=O)Cc2cc(-c3ccc(F)cc3)ccc2C)CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 1/20 0.40
SCN9A Q15858 1/20 0.40
OPRM1 P35372 2/20 0.37
CNR2 P34972 4/20 0.36
CNR1 P21554 3/20 0.36
DGAT2 Q96PD7 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 1/20 0.35
HDAC4 P56524 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
OPRD1 P41143 1/20 0.34
LATS1 O95835 1/20 0.34
MGLL Q99685 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6739957 0.91 CTSL (0.39) OPRM1CNR2CNR1SMN1; SMN2
SCHEMBL812375 0.83 CTSL (0.40) OPRM1CNR2CNR1SMN1; SMN2
SCHEMBL12479482 0.82 CNR1 (0.34) FPR2SCN9ACNR2CNR1MAPT
SCHEMBL12029926 0.81 ANO1 (0.41) HDAC1HDAC2ANO1
SCHEMBL2387897 0.80 CNR1 (0.37) CNR2CNR1HDAC1HDAC2MEN1
SCHEMBL27781318 0.80 CNR2 (0.34) CNR2CNR1MAPTHDAC4ALDH1A1
SCHEMBL12029984 0.80 OPRM1 (0.38) FPR2SCN9AOPRM1HDAC1HDAC2
SCHEMBL2375831 0.79 FPR2 (0.36) FPR2SCN9AOPRM1CNR2CNR1
SCHEMBL8862797 0.78 POLB (0.40) L3MBTL1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL8862538 0.78 POLB (0.40) L3MBTL1MEN1KMT2ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099751-B1 BIPHENYL-SUBSTITUTED SPIROCYCLIC KETOENOLS BAYER IP GMBH (DE) 2018-05-30 EP disclosed
US-9000189-B2 Biphenyl-substituted spirocyclic ketoenols BAYER CROPSCIENCE AG (DE) 2015-04-07 US disclosed
US-9000189-B2 Biphenyl-substituted spirocyclic ketoenols BAYER CROPSCIENCE AG (DE) 2015-04-07 US disclosed
US-20110306499-A1 Biphenyl-Substituted Spirocyclic Ketoenols BAYER CROPSCIENCE AG (DE) 2011-12-15 US disclosed
US-20110306499-A1 Biphenyl-Substituted Spirocyclic Ketoenols BAYER CROPSCIENCE AG (DE) 2011-12-15 US disclosed
WO-2008067911-A1 BIPHENYL-SUBSTITUTED SPIROCYCLIC KETOENOLS BAYER CROPSCIENCE AG (DE) 2008-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306499-A1 Biphenyl-Substituted Spirocyclic Ketoenols KCNE1, PDHX, PIKFYVE FPR2 4771/4885SCN9A 2353/4885OPRM1 3603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.